Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachelle W Johnson

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Bone Oncology|October 16, 2023
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanismsGwenyth J Joseph, Douglas B Johnson, Rachelle W Johnson
Current Osteoporosis Reports|June 10, 2017
Hypoxia and Bone Metastatic DiseaseRachelle W Johnson, Miranda E Sowder, Amato J Giaccia
Journal of Bone Oncology|February 18, 2026
Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markersDéja M Grant, Gwenyth J Joseph, Madeline Searcy, et al.
JBMR Plus|March 20, 2023
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate TherapyMiranda E Clements, Lauren Holtslander, Joshua R Johnson, et al.
Bone|April 12, 2014
Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiationRachelle W Johnson, Jason D White, Emma C Walker, et al.
Journal of Bone Oncology|December 22, 2021
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancerCourtney M Edwards, Miranda E Clements, Lawrence A Vecchi, et al.
Oncoimmunology|December 25, 2012
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destructionSabrina Danilin, Alyssa R Merkel, Joshua R Johnson, et al.
Anticancer Research|August 27, 2011
6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2Rachelle W Johnson, Alyssa R Merkel, Sabrina Danilin, et al.
Bone|August 6, 2010
Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destructionLindsay C Johnson, Rachelle W Johnson, Steve A Munoz, et al.
JBMR Plus|December 19, 2022
Sex-Specific Differences in G<sub>s</sub>α-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in BoneSrilatha Swami, Joshua Johnson, Lawrence A Vecchi, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Bone Oncology|October 16, 2023
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanismsGwenyth J Joseph, Douglas B Johnson, Rachelle W Johnson
Current Osteoporosis Reports|June 10, 2017
Hypoxia and Bone Metastatic DiseaseRachelle W Johnson, Miranda E Sowder, Amato J Giaccia
Journal of Bone Oncology|February 18, 2026
Digital spatial profiling of α-PD-1 treated breast cancer bone metastases reveals region-specific signaling and enrichment of immune-suppressive markersDéja M Grant, Gwenyth J Joseph, Madeline Searcy, et al.
JBMR Plus|March 20, 2023
Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate TherapyMiranda E Clements, Lauren Holtslander, Joshua R Johnson, et al.
Bone|April 12, 2014
Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiationRachelle W Johnson, Jason D White, Emma C Walker, et al.
Journal of Bone Oncology|December 22, 2021
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancerCourtney M Edwards, Miranda E Clements, Lawrence A Vecchi, et al.
Oncoimmunology|December 25, 2012
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destructionSabrina Danilin, Alyssa R Merkel, Joshua R Johnson, et al.
Anticancer Research|August 27, 2011
6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2Rachelle W Johnson, Alyssa R Merkel, Sabrina Danilin, et al.
Bone|August 6, 2010
Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destructionLindsay C Johnson, Rachelle W Johnson, Steve A Munoz, et al.
JBMR Plus|December 19, 2022
Sex-Specific Differences in G<sub>s</sub>α-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in BoneSrilatha Swami, Joshua Johnson, Lawrence A Vecchi, et al.
Pageof 6